Clinical Trials Logo
  1. Home
  2. Stomach Ulcer
  3. NCT00125736

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

Stomach Ulcer Clinical Trial

Official title:
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of combination use of E0671 and Rabeprazole Sodium in patients with gastric ulcer.

Clinical Trial Description

The efficacy and safety of E0671 in combination with Rabeprazole Sodium (i.e., 10 mg/day of rabeprazole sodium and 150 mg/day of E0671) will be investigated in patients with gastric ulcer in a multicenter, randomized, double-blind, parallel-group comparative study using a placebo control group (10 mg/day of rabeprazole sodium and placebo for E0671). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00125736
Study type Interventional
Source Eisai Inc.
Contact
Status Completed
Phase Phase 4
Start date August 1, 2005
Completion date April 19, 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT02299687 - Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole Phase 1
Completed NCT00284908 - Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers Phase 1
Completed NCT00239551 - Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer Phase 4
Completed NCT02710994 - Pharmacodynamics and Safety of CDFR0209 Phase 1
Completed NCT01167101 - Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? N/A
Terminated NCT00762359 - A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers Phase 3
Completed NCT01376414 - H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department N/A
Completed NCT00543868 - MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) Phase 2
Completed NCT05208268 - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Completed NCT02032030 - Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
Completed NCT00272467 - Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy Phase 4
Completed NCT03060746 - Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Completed NCT03060733 - Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Completed NCT00233389 - Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer Phase 4
Terminated NCT00839488 - Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis Phase 4
Completed NCT00787254 - Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Phase 3
Completed NCT00190255 - Pharmacogenetics of Gastrointestinal Bleeding Phase 4